Scryb Inc
CNSX:SCYB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Scryb Inc
Revenue
Scryb Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Scryb Inc
CNSX:SCYB
|
Revenue
CA$429.6k
|
CAGR 3-Years
-13%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Revenue
$16.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Revenue
CA$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-4%
|
|
|
MedMira Inc
XTSX:MIR
|
Revenue
CA$188.5k
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
-29%
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Revenue
CA$2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Revenue
$706k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Scryb Inc
Glance View
Scryb, Inc. operates as a medical technology company, which engages in the development of novel medical devices for in vitro diagnostics and point-of-care testing. The company is headquartered in Etobicoke, Ontario. The Company’s platform offers businesses and technologies with applied intelligence, real-time analytics, and actionable insights. The platform adopts across diverse markets, from digital health and diagnostics to cybersecurity and manufacturing. The Company’s cloud-based platform is composed of elements including sensor technology, Internet of things (IoT), predictive analytics, and computer vision. Its portfolio includes Pharmatrac, Fionet, Handheld Diagnostics and Cybeats. Pharmatrac is an artificial intelligence (AI) digital health company that provides insight into medication behavior. Fionet is a data-and-device platform that enables controlled testing and tracking for pandemic response. Handheld Diagnostics brings lab-quality analysis to bedside in critical care situations. Cybeats builds certainty in software security.
See Also
What is Scryb Inc's Revenue?
Revenue
429.6k
CAD
Based on the financial report for Sep 30, 2025, Scryb Inc's Revenue amounts to 429.6k CAD.
What is Scryb Inc's Revenue growth rate?
Revenue CAGR 3Y
-13%
Over the last year, the Revenue growth was -77%. The average annual Revenue growth rates for Scryb Inc have been -13% over the past three years .